María Teresa Á. R.
- Country
- Spain
- Department
- Hematology
Research Overview
- A Multicenter, Randomized, Open-Label Study Comparing Romiplostim Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia
- Open-Label Multinational Study of Fitusiran Prophylaxis in Pediatric Patients Aged 1 to <12 Years with Severe Hemophilia A or B
- Efficacy and Safety Evaluation of Rilzabrutinib in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia: A Phase 3 Randomized Study
Data & Insights
Has run more than one trial at 56 of 139 partner sites.
Specializations
Hematological Disorders
The investigator specializes in treating hemophilia A and B, with particular focus on prophylactic treatment approaches and management of complications.
- Severe and moderately severe hemophilia
- Pediatric hemophilia care
- Perioperative management
The research extends to evaluating joint outcomes and synovial health in hemophilia patients.
Autoimmune Conditions
Primary focus includes the treatment of immune thrombocytopenia (ITP), investigating both established and novel therapeutic approaches.
- Newly diagnosed ITP
- Refractory/relapsed ITP
- Combination therapy approaches
The investigator examines sustained platelet response and bleeding prevention strategies.
Special Populations
Dedicated research in gender-specific hematological care, particularly focusing on women and girls with bleeding disorders.
- Female-specific hemophilia treatment
- Surgical management in women
- Pediatric blood disorders
Expertise includes tailoring treatments for specific patient demographics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.